156 related articles for article (PubMed ID: 30111376)
1. Per-organ assessment of subject-induced susceptibility distortion for MR-only male pelvis treatment planning.
Glide-Hurst C; Nejad-Davarani S; Weiss S; Zheng W; Chetty IJ; Renisch S
Radiat Oncol; 2018 Aug; 13(1):149. PubMed ID: 30111376
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional MRI evaluation of the effect of bladder volume on prostate translocation and distortion.
Snoj Z; Gill AB; Rundo L; Sushentsev N; Barrett T
Radiol Oncol; 2020 Jan; 54(1):48-56. PubMed ID: 31940289
[TBL] [Abstract][Full Text] [Related]
3. Do differences in target volume definition in prostate cancer lead to clinically relevant differences in normal tissue toxicity?
Livsey JE; Wylie JP; Swindell R; Khoo VS; Cowan RA; Logue JP
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1076-81. PubMed ID: 15519777
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy.
Roeske JC; Forman JD; Mesina CF; He T; Pelizzari CA; Fontenla E; Vijayakumar S; Chen GT
Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1321-9. PubMed ID: 7493857
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging in postprostatectomy radiotherapy planning.
Sefrova J; Odrazka K; Paluska P; Belobradek Z; Brodak M; Dolezel M; Prosvic P; Macingova Z; Vosmik M; Hoffmann P; Louda M; Nejedla A
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):911-8. PubMed ID: 21420244
[TBL] [Abstract][Full Text] [Related]
6. Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer.
de Crevoisier R; Melancon AD; Kuban DA; Lee AK; Cheung RM; Tucker SL; Kudchadker RJ; Newhauser WD; Zhang L; Mohan R; Dong L
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1529-36. PubMed ID: 17544595
[TBL] [Abstract][Full Text] [Related]
7. [Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results].
Sefrová J; Paluska ; Odrázka K; Belobradek Z; Hoffmann P; Prosvic P; Brod'ák M; Louda M; Macingová Z; Vosmik M
Klin Onkol; 2010; 23(4):256-63. PubMed ID: 20806824
[TBL] [Abstract][Full Text] [Related]
8. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C
Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187
[TBL] [Abstract][Full Text] [Related]
9. Characterization of tissue magnetic susceptibility-induced distortions for MRIgRT.
Stanescu T; Wachowicz K; Jaffray DA
Med Phys; 2012 Dec; 39(12):7185-93. PubMed ID: 23231269
[TBL] [Abstract][Full Text] [Related]
10. Technical Note: On the size of susceptibility-induced MR image distortions in prostate and cervix in the context of MR-guided radiation therapy.
Emmerich J; Laun FB; Pfaffenberger A; Schilling R; Denoix M; Maier F; Sterzing F; Bostel T; Straub S
Med Phys; 2018 Apr; 45(4):1586-1593. PubMed ID: 29394448
[TBL] [Abstract][Full Text] [Related]
11. Implications of tissue magnetic susceptibility-related distortion on the rotating magnet in an MR-linac design.
Wachowicz K; Stanescu T; Thomas SD; Fallone BG
Med Phys; 2010 Apr; 37(4):1714-21. PubMed ID: 20443492
[TBL] [Abstract][Full Text] [Related]
12. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
[TBL] [Abstract][Full Text] [Related]
13. Automatic segmentation of pelvic structures from magnetic resonance images for prostate cancer radiotherapy.
Pasquier D; Lacornerie T; Vermandel M; Rousseau J; Lartigau E; Betrouni N
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):592-600. PubMed ID: 17498571
[TBL] [Abstract][Full Text] [Related]
14. A novel and rapid approach to estimate patient-specific distortions based on mDIXON MRI.
Weiss S; Nejad-Davarani S; Eggers H; Orasanu E; Renisch S; Glide-Hurst C
Phys Med Biol; 2019 Aug; 64(15):155002. PubMed ID: 31216529
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the 4D composite MR image distortion field associated with tumor motion for MR-guided radiotherapy.
Stanescu T; Jaffray D
Med Phys; 2016 Mar; 43(3):1550-62. PubMed ID: 26936738
[TBL] [Abstract][Full Text] [Related]
16. Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.
Rijkhorst EJ; Lakeman A; Nijkamp J; de Bois J; van Herk M; Lebesque JV; Sonke JJ
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1254-60. PubMed ID: 19857789
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes.
Yoo S; Wu QJ; Lee WR; Yin FF
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):935-42. PubMed ID: 20044214
[TBL] [Abstract][Full Text] [Related]
18. Continuous table acquisition MRI for radiotherapy treatment planning: distortion assessment with a new extended 3D volumetric phantom.
Walker A; Liney G; Holloway L; Dowling J; Rivest-Henault D; Metcalfe P
Med Phys; 2015 Apr; 42(4):1982-91. PubMed ID: 25832089
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
Qin A; Sun Y; Liang J; Yan D
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
[TBL] [Abstract][Full Text] [Related]
20. Pelvic nodal dosing with registration to the prostate: implications for high-risk prostate cancer patients receiving stereotactic body radiation therapy.
Kishan AU; Lamb JM; Jani SS; Kang JJ; Steinberg ML; King CR
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):832-9. PubMed ID: 25752398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
